Persistence with Early-Line Abatacept versus Tumor Necrosis Factor-Inhibitors for Rheumatoid Arthritis Complicated by Poor Prognostic Factors
**Background:** Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by joint swelling and destruction that leads to severe disability. There are no clear guidelines regarding the order of therapies. Gathering data on treatment patterns outside of a cli...
Saved in:
Main Authors: | Xue Han, Francis Lobo, Michael S. Broder, Eunice Chang, Sarah N. Gibbs, David J. Ridley, Irina Yermilov |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2021-05-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/jheor.2021.23684 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Distinguishing rheumatoid arthritis from psoriatic arthritis
by: Joseph F Merola, et al.
Published: (2018-08-01) -
Exploring the predictive power of antinuclear antibodies and Rheumatoid factor correlations in anticipating therapeutic outcomes for female patients with coexisting Sjögren's syndrome and Rheumatoid arthritis
by: Anitha Krishnan Pandarathodiyil, et al.
Published: (2025-03-01) -
Characteristics of Sjögren’s syndrome associated with rheumatoid arthritis
by: Xavier Mariette, et al.
Published: (2022-02-01) -
Targeted Therapy for Rheumatoid Arthritis in the New Era
by: WANG Jun, et al.
Published: (2025-01-01) -
Clinical and Immunological Characteristics of Elderly Onset Rheumatoid Arthritis
by: LI Zhengfang, et al.
Published: (2025-01-01)